[3H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetaimne and p-chloroamphetamine analogues
- 23 July 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 200 (1) , 9-16
- https://doi.org/10.1016/0014-2999(91)90659-e
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA)Journal of Medicinal Chemistry, 1991
- 5-iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetaminePharmacology Biochemistry and Behavior, 1991
- Nonneurotoxic tetralin and indan analogs of 3,4-(methylenedioxy)amphetamine (MDA)Journal of Medicinal Chemistry, 1990
- Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administrationPharmacology Biochemistry and Behavior, 1989
- Evidence for dual serotonergic projections to neocortex: Axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA)Experimental Neurology, 1988
- Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic classJournal of Medicinal Chemistry, 1986
- p-Chloroamphetamine: Selective Neurotoxic Action in BrainScience, 1975
- The hepatic microsomal metabolism of β-3,4-methylenedioxyamphetamine (MDA)Life Sciences, 1974
- Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole metabolism in ratsNeuropharmacology, 1974
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966